Inuence of combined oral contraception with progestin dominancy on uterine fibroid development

Trial Profile

Inuence of combined oral contraception with progestin dominancy on uterine fibroid development

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jul 2012

At a glance

  • Drugs Ethinylestradiol/gestodene (Primary)
  • Indications Uterine leiomyoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jul 2012 New trial record
    • 23 Jun 2012 Results presented at the 12th Congress of the European Society of Contraception.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top